Search - tctmd.com

Displaying 21 - 40 of 51

Sort: Relevancy | Date

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Conference News EuroPCR 2017

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Shelley Wood

June 02, 2017

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Conference News EuroPCR 2017

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Shelley Wood

May 17, 2017

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

News Conference News EuroPCR 2016

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Michael O'Riordan

May 19, 2016

Presentation EuroPCR 2016

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

Presenter: Mayra Guerrero

May 18, 2016

News Conference News EuroPCR 2016

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

Shelley Wood

May 18, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

News Conference News EuroPCR 2016

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

Caitlin E. Cox

May 17, 2016

Advertisement

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

More Early Stroke With SAVR Than TAVR in SURTAVI

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content